Title of Document : CHARACTERIZATION OF THE N - ACETYLGLUTAMATE SYNTHASE KNOCKOUT MOUSE , A NOVEL MODEL OF HYPERAMMONEMIA
نویسندگان
چکیده
Title of Document: CHARACTERIZATION OF THE NACETYLGLUTAMATE SYNTHASE KNOCKOUT MOUSE, A NOVEL MODEL OF HYPERAMMONEMIA. Emilee Senkevitch, PhD, 2012 Directed By: Professor Mendel Tuchman, Department of Pediatrics, Children's National Medical Center, George Washington University Professor David Mosser, Department of Cell Biology and Molecular Genetics All knockout mouse models of urea cycle disorders die in the neonatal period or shortly thereafter. Since N-acetylglutamate synthase (NAGS) deficiency in humans can be effectively treated with N-carbamyl-L-glutamate (NCG), we sought to develop a mouse model of this disorder that could be rescued by biochemical intervention, reared to adulthood, reproduce, and become a novel animal model for hyperammonemia. NCG and L-citrulline (Cit) were used to rescue the NAGS knockout homozygous (Nags) pups and the rescued animals were characterized. This regimen has allowed for normal development, apparent health, and reproduction. Interruption of this rescue intervention resulted in the development of severe hyperammonemia and death within 48 hours. We have developed a home cage behavioral system that allows to monitor and analyze the chronology of animal behaviors during healthy and hyperammonemic states. Data collected from this study reveals that mice decrease their normal activity around 12 hours and become severely lethargic by 20 hours following NCG withdrawal. Understanding the chronology of hyperammonemia will aid in future studies to discover neuro-protective drugs for treating hyperammonemia. This mouse model will also allow studies of the pharmacokinetics and pharmacodynamics of NCG, much of which is still unknown. Understanding how NCG is transported into cells and then cleared is clinically relevant and can potentially lead to more efficient administration of this drug. We conclude that a novel NAGS deprived mouse model has been developed which can be rescued by NCG and Cit and reared to reproduction and beyond. This biochemically salvageable mouse model recapitulates the clinical phenotype of proximal urea cycle disorders and can be used as a reliable model of induced hyperammonemia by manipulating the administration of the rescue compounds. CHARACTERIZATION OF THE N-ACETYLGLUTAMATE SYNTHASE KNOCKOUT MOUSE, A NOVEL MODEL OF HYPERAMMONEMIA
منابع مشابه
N-acetylglutamate synthase deficiency: Novel mutation associated with neonatal presentation and literature review of molecular and phenotypic spectra
The urea cycle is the main pathway for the disposal of excess nitrogen. Carbamoylphosphate synthetase 1 (CPS1), the first and rate-limiting enzyme of urea cycle, is activated by N-acetylglutamate (NAG), and thus N-acetylglutamate synthase (NAGS) is an essential part of the urea cycle. Although NAGS deficiency is the rarest urea cycle disorder, it is the only one that can be specifically and eff...
متن کاملRole of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency
N-acetylglutamate synthase (NAGS) deficiency is a rare inborn error of metabolism affecting ammonia detoxification in the urea cycle. The product of NAGS is N-acetylglutamate which is the absolutely required allosteric activator of the first urea cycle enzyme carbamoylphosphate synthetase 1. In defects of NAGS, the urea cycle function can be severely affected resulting in fatal hyperammonemia i...
متن کاملNew developments in the treatment of hyperammonemia: emerging use of carglumic acid
Hyperammonemia is a true neonatal emergency with high toxicity for the central nervous system and developmental delay. The causes of neonatal hyperammonemia are genetic defects of urea cycle enzymes, organic acidemias, lysinuric protein intolerance, hyperammonemia-hyperornithinemia- homocitrullinemia syndrome, transient hyperammonemia of the newborn, and congenital hyperinsulinism with hyperamm...
متن کاملInhibition of carbamoyl-phosphate synthase (ammonia) by Tris and Hepes. Effect on Ka for N-acetylglutamate.
The apparent Ka for N-acetylglutamate of rat liver carbamoyl-phosphate synthase is 11 microM in phosphate buffer, a value 10-fold lower than reported in other buffer systems. Tris and Hepes inhibit competitively with N-acetylglutamate. The proportion of carbamoyl-phosphate synthase in the active enzyme-acetylglutamate complex in vivo may be higher than previous calculations suggest, which re-op...
متن کاملHuman hepatic N-acetylglutamate content and N-acetylglutamate synthase activity. Determination by stable isotope dilution.
N-Acetyl-L-glutamate (N-acetylglutamate) content and N-acetylglutamate synthase activity ranges were established in human liver tissue homogenates by stable isotope dilution. The methods employ N-[methyl-2H3]acetyl[15N]glutamate as internal standard, extraction of N-acetylglutamate by anion-exchange technique and its determination by g.l.c.-mass spectrometry by using selected ion monitoring. He...
متن کامل